ストックスクリーナーアプリを入手
0.38
0.05%
-0.0002
アフターアワーズ：
.36
-0.02
-5.26%
前日終値:
$0.3802
開ける：
$0.356
24時間の取引高:
401.80K
Relative Volume:
0.07
時価総額：
$16.39M
収益：
$3.50M
当期純損益:
$-37.33M
株価収益率:
-0.38
EPS:
-1
ネットキャッシュフロー:
$-19.15M
1週間 パフォーマンス:
+1.36%
1か月 パフォーマンス:
-40.24%
6か月 パフォーマンス:
-9.52%
1年 パフォーマンス:
-75.16%
1日の値動き範囲:
$0.356
$0.39
1週間の範囲:
$0.35
$0.39
52週間の値動き範囲:
$0.2103
$2.52
Hcw Biologics Inc Stock (HCWB) Company Profile
HCWB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
0.38 | 16.39M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Hcw Biologics Inc (HCWB) 最新ニュース
HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com
HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News
HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater
Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex
The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks
HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Penny Stocks To ResearchFebruary 03rd - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Pharma company granted FDA clearance for alopecia drug study - The Business Journals
Crude Oil Moves Higher; Owens & Minor Shares Plummet - Benzinga
FDA approves HCW Biologics trial for alopecia treatment - MSN
What's Going On With HCW Biologics Stock Monday? - Benzinga
A Potential Breakthrough in the Fight Against Alopecia Areata: What You Need to Know About HCW Biologics Inc. - RagingBull
Stock market news: MDJM surged by 74.54% while Tonix Pharmaceuticals Holding plunged by 49.31% during mid day trading - Business Upturn
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January - Benzinga
S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results - Benzinga
HCW Biologics Advances with FDA Clearance for Trial - TipRanks
Stock market today: Tonix Pharmaceuticals Holding declined by 49.01% whereas HCW Biologics jumped by 176.78% in early trading - Business Upturn
HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell - Marketscreener.com
HCW Biologics Granted FDA Clearance to Evaluate One of the - GlobeNewswire
HCW Biologics Granted FDA Clearance to Evaluate One of the Company?s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - Marketscreener.com
HCWB stock touches 52-week low at $0.25 amid market challenges - Investing.com Australia
HCW Biologics (NASDAQ:HCWB) Shares Down 20% – Here’s Why - Defense World
HCWB stock touches 52-week low at $0.25 amid market challenges By Investing.com - Investing.com South Africa
HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m - Yahoo Finance
HCW Biologics (HCWB) Stock Price, News & Analysis - MarketBeat
HCW Biologics : January 2025. - Marketscreener.com
HCW Biologics’ Founder and CEO to Address Opportunities and - GlobeNewswire
HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 - The Manila Times
HCW Biologics CEO to Share Breakthrough Immunotherapy Insights at 2025 GenScript Forum - StockTitan
HCW Biologics (NASDAQ:HCWB) Stock Price Up 1.2% – Here’s What Happened - Defense World
HCW Announces Written Notice From NASDAQ - MENAFN.COM
HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq - Marketscreener.com
HCW Announces Written Notice from NASDAQ - Baystreet.ca
HCW Biologics Inc. Received NASDAQ Staff Determination Letter - GlobeNewswire
HCW Biologics Faces Nasdaq Delisting Threat After Market Value Falls Below $50M Requirement - StockTitan
HCW Biologics Inc. Receives Nasdaq Delisting Notice, Plans to Appeal for Continued Listing - Nasdaq
HCW Biologics issues 2.55 million shares to Armistice Capital By Investing.com - Investing.com Nigeria
HCW Biologics issues 2.55 million shares to Armistice Capital - Investing.com India
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
HCW Biologics takes aim at CD8+ in deal with WY Biotech - The Pharma Letter
HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - MSN
HCW Biologics : Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules Form 8 K - Marketscreener.com
HCW Biologics Expands with New Financial Agreements - TipRanks
Hcw Biologics Inc (HCWB) 財務データ
収益
当期純利益
現金流量
EPS
6.45%
1.23%
大文字化:
|
ボリューム (24 時間):